The construction of recombinant CEA gene vaccine and its immune effect

XIONG Wei,DUAN Xiu-Mei,FANG Yan-Qiu,LIU Li-Hua,JIANG Yan-Fang,TAN Yan
2006-01-01
Abstract:Objective:To investigate the possibility that the eukaryotic expression plasmid pIRES-CEAⅢ was used to therapy tumor expression CEA. Methods:The coding sequence for signal peptide and the third domain of CEA was inserted into the eukaryotic expression plasmid pIRES-neo using gene recombinant technique. BALB/c mice were immunized intramuscularly with recombinant plasmid vaccine and inoculated sc by the wildtype mice hepatocellular carcinoma cell line of H22 and H22 transfected with plasmid containing the full sequence of CEAcDNA. Tumor sizes were observed and the specific CTL cytotoxicity of the mice was detected. Results:Compared with the control,the tumors in mice immunized with pIRES-CEAⅢ were significantly inhibited(P <0.05). The splenic cells of mice immunized with pIRES-CEAⅢ possess strongly the cytotoxicity against tumor H22-CEA(+) (P < 0. 05 or P < 0.01). Conclusion :pIRES-CEAⅢ vaccine can suppress the growth of tumor expressing CEA and elicit CTL response against CEA antigen.
What problem does this paper attempt to address?